Catalio Capital Management, LP
Top Portfolio Positions
41 positions ·
$478,705,573 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio |
|---|---|---|---|---|
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
560,308 | $47,021,047 | 9.82% |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
432,014 | $32,081,359 | 6.70% |
| ASND |
Ascendis Pharma A/S
Healthcare
|
129,111 | $29,531,559 | 6.17% |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
420,727 | $25,517,092 | 5.33% |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
1,043,670 | $24,380,131 | 5.09% |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
163,905 | $22,843,439 | 4.77% |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
409,031 | $21,564,114 | 4.50% |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
1,037,984 | $19,617,897 | 4.10% |
| SLNO |
Soleno Therapeutics Inc
Healthcare
|
577,808 | $19,345,011 | 4.04% |
| BSX |
Boston Scientific Corp
Healthcare
|
299,318 | $18,782,204 | 3.92% |
Holdings in DNTH
Export CSV
1 of 1 shown
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,021,047 | 560,308 | Shares | Sole | 2026-05-15 | |
| No quarters match your search. | ||||||